John Hancock Classic Value Fund Class R2 (JCVSX)
| Fund Assets | 513.34M |
| Expense Ratio | 1.29% |
| Min. Investment | $1,000 |
| Turnover | 13.00% |
| Dividend (ttm) | 6.98 |
| Dividend Yield | 38.19% |
| Dividend Growth | -43.40% |
| Payout Frequency | Annual |
| Ex-Dividend Date | Dec 19, 2025 |
| Previous Close | 18.27 |
| YTD Return | -6.83% |
| 1-Year Return | 3.02% |
| 5-Year Return | 14.44% |
| 52-Week Low | 18.02 |
| 52-Week High | 26.58 |
| Beta (5Y) | n/a |
| Holdings | 35 |
| Inception Date | Mar 1, 2012 |
About JCVSX
John Hancock Classic Value Fund Class R2 is a mutual fund designed primarily to deliver long-term capital growth by investing at least 80% of its net assets in domestic equity securities. The fund follows a value-oriented strategy, targeting companies that are considered undervalued relative to their intrinsic worth. This focus makes the fund particularly relevant for investors seeking exposure to U.S. stocks with strong fundamentals trading at attractive valuations. John Hancock Classic Value Fund Class R2 spreads its investments across a diverse range of sectors, aiming to provide broad market representation within its value discipline. The fund offers Class R2 shares, which are commonly utilized in retirement plans and feature competitive expense structures along with specific service fee arrangements. Its role in the financial market is to serve as a portfolio component that can potentially offer stability and growth by emphasizing value stocks, thus appealing to investors looking to diversify equity holdings through a disciplined, research-driven approach.
Performance
JCVSX had a total return of 3.02% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.61%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FVLCX | Fidelity | Fidelity Advisor Value Leaders Fund | 1.90% |
| FSLVX | Fidelity | Fidelity Stock Selector Large Cap Value Fund | 0.83% |
| SWLVX | Schwab | Schwab U.S. Large-Cap Value Index Fund | 0.03% |
| FVLIX | Fidelity | Fidelity Advisor Value Leaders Fund | 0.90% |
| FSCZX | Fidelity | Fidelity Advisor Stock Selector Large Cap Value Fund - Class Z | 0.72% |
Top 10 Holdings
43.75% of assets| Name | Symbol | Weight |
|---|---|---|
| Baxter International Inc. | BAX | 5.13% |
| CVS Health Corporation | CVS | 5.07% |
| Humana Inc. | HUM | 5.05% |
| Citigroup Inc. | C | 4.76% |
| Wells Fargo & Company | WFC | 4.22% |
| Capital One Financial Corporation | COF | 4.18% |
| Fresenius Medical Care AG | FMS | 4.07% |
| Dollar General Corporation | DG | 3.97% |
| Magna International Inc. | MG | 3.82% |
| MetLife, Inc. | MET | 3.48% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 19, 2025 | $6.97748 | Dec 22, 2025 |
| Dec 20, 2024 | $12.32735 | Dec 23, 2024 |
| Dec 19, 2023 | $2.14443 | Dec 20, 2023 |
| Dec 19, 2022 | $5.92992 | Dec 20, 2022 |
| Dec 17, 2021 | $0.18375 | Dec 20, 2021 |
| Dec 18, 2020 | $0.36777 | Dec 21, 2020 |